JPH05310659A - 新規な4−アミノ−5−ヘキセン酸の製法 - Google Patents
新規な4−アミノ−5−ヘキセン酸の製法Info
- Publication number
- JPH05310659A JPH05310659A JP4351078A JP35107892A JPH05310659A JP H05310659 A JPH05310659 A JP H05310659A JP 4351078 A JP4351078 A JP 4351078A JP 35107892 A JP35107892 A JP 35107892A JP H05310659 A JPH05310659 A JP H05310659A
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- hexenoate
- amino
- converted
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PJDFLNIOAUIZSL-UHFFFAOYSA-N vigabatrin Chemical compound C=CC(N)CCC(O)=O PJDFLNIOAUIZSL-UHFFFAOYSA-N 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000006243 chemical reaction Methods 0.000 claims abstract description 11
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 8
- 239000004386 Erythritol Substances 0.000 claims abstract description 6
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940009714 erythritol Drugs 0.000 claims abstract description 6
- 235000019414 erythritol Nutrition 0.000 claims abstract description 6
- DRUIESSIVFYOMK-UHFFFAOYSA-N Trichloroacetonitrile Chemical compound ClC(Cl)(Cl)C#N DRUIESSIVFYOMK-UHFFFAOYSA-N 0.000 claims abstract description 4
- AGGDACKPJYQQTJ-UHFFFAOYSA-N ethyl 6-hydroxyhex-4-enoate Chemical compound CCOC(=O)CCC=CCO AGGDACKPJYQQTJ-UHFFFAOYSA-N 0.000 claims abstract description 4
- YVCNXMGONDDLBG-UHFFFAOYSA-N 3-hydroxypent-4-enal Chemical compound C=CC(O)CC=O YVCNXMGONDDLBG-UHFFFAOYSA-N 0.000 claims abstract description 3
- JLIXDVYXSMNNOY-UHFFFAOYSA-N ethyl 6-formyloxyhex-4-enoate Chemical compound CCOC(=O)CCC=CCOC=O JLIXDVYXSMNNOY-UHFFFAOYSA-N 0.000 claims abstract description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims abstract 2
- ISYPOFVXIZTQMA-UHFFFAOYSA-N ethyl 6-(2,2,2-trichloroethanimidoyl)oxyhex-4-enoate Chemical compound CCOC(=O)CCC=CCOC(=N)C(Cl)(Cl)Cl ISYPOFVXIZTQMA-UHFFFAOYSA-N 0.000 claims abstract 2
- -1 ethyl formyloxy-4-hexenoate Chemical compound 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- SJRXWMQZUAOMRJ-UHFFFAOYSA-N ethyl 2-hexenoate Chemical compound CCCC=CC(=O)OCC SJRXWMQZUAOMRJ-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical compound Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 abstract description 5
- 239000007858 starting material Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 238000003379 elimination reaction Methods 0.000 abstract description 2
- 239000003112 inhibitor Substances 0.000 abstract description 2
- 230000008707 rearrangement Effects 0.000 abstract 3
- 102100035923 4-aminobutyrate aminotransferase, mitochondrial Human genes 0.000 abstract 1
- 238000005821 Claisen rearrangement reaction Methods 0.000 abstract 1
- 101001000686 Homo sapiens 4-aminobutyrate aminotransferase, mitochondrial Proteins 0.000 abstract 1
- NKTXPLUMJAFZLC-UHFFFAOYSA-N ethyl 4-[(2,2,2-trichloroacetyl)amino]hex-5-enoate Chemical compound CCOC(=O)CCC(C=C)NC(=O)C(Cl)(Cl)Cl NKTXPLUMJAFZLC-UHFFFAOYSA-N 0.000 abstract 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 229910004298 SiO 2 Inorganic materials 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000003818 flash chromatography Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- DLPNYKZTMBRGLC-UHFFFAOYSA-N 2-hydroxybut-3-enyl formate Chemical compound C=CC(O)COC=O DLPNYKZTMBRGLC-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000006276 transfer reaction Methods 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229960005318 vigabatrin Drugs 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- JJBDOMRIWVENMR-UHFFFAOYSA-N CCC(CC=CC)(C(=O)O)O Chemical compound CCC(CC=CC)(C(=O)O)O JJBDOMRIWVENMR-UHFFFAOYSA-N 0.000 description 1
- 101000913968 Ipomoea purpurea Chalcone synthase C Proteins 0.000 description 1
- 101000907988 Petunia hybrida Chalcone-flavanone isomerase C Proteins 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229940106773 sabril Drugs 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000010512 thermal transition Effects 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
- C07C211/24—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
- C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/04—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
- C07C257/06—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers having carbon atoms of imino-carboxyl groups bound to hydrogen atoms, to acyclic carbon atoms, or to carbon atoms of rings other than six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
新規な合成方法並びにその製造中間体を提供する。 【構成】 次の反応式に従いエリスリトール(式1)か
ら4−アミノ−5−ヘキセン酸(式7)を製造する方
法。
Description
−アミノ−5−ヘキセン酸の新規な合成及びそれによっ
て製造される新規な中間体に関する。
GABAとして知られている4−アミノ−5−ヘキセン
酸は、癲癇の治療のためにサブリル(SABRIL登録
商標)の商品名のもとで取り引きされているGABA−
T阻害剤である(S. M. グラント(Grant)らドラッグス
(Drugs)41(6):889-926,1991によるビガバトリンにつ
いての評価記事(review article on vigabatrin)を参
照)。
−ルから出発する既知の熱反応に基づいており、この熱
反応は(1)二重結合を形成するための脱離反応、
(2)クライゼン転移及び(3)オバ−マン転移であ
る。関与する反応経路は次の反応経路に描かれる。
(1)から4−ホルミロキシ−3−ヒドロキシ−1−ブ
テン(2)を製造するための知られた熱転移反応を含ん
でいる(プロボスト(Provost) C.Ann.Chem. [10], 10,
398, 1928を参照)。ワ−クアップは必要ではないが、
生成物を再蒸留したときにより純粋な化合物のより良い
収率が得られる。段階(b)は第2の熱転移反応を含ん
でおり、これに加水分解が続く。ここで4−ホルミル−
3−ヒドロキシ−1−ブテンが140〜150℃で過剰
量のオルトアセテ−ト(4対1)の存在下でその場で製
造されたアルコ−ルを除去する条件下で加熱される(ジ
ョンソン(Johnson) W.及び コル(Coll),J.Am.Chem.So
c. 92, 741, 1970を参照)。続く加水分解と過剰のオル
トアセテ−トの除去に続いて、そのようにして製造され
た6−ホルミロキシ−4−ヘキセン酸エチルはそのまま
使用でき、又はこれは任意付加的に精製のために蒸留に
かけられ、又はSiO2上のフラッシュクロマトグラフ
ィにかけることができる。別の方法として、この熱転移
は140〜150℃付近で沸騰する不活性溶媒(例えば
キシレン)中でオルトアセテ−トの1当量を使用して実
施できる。これらの反応に対する反応時間は蒸留される
アルコ−ル(メタノ−ル又はエタノ−ル)の測定によっ
てモニタ−できる。
ガスが加えられている無水エタノ−ル中で約15〜25
℃の温度でホルメ−トを攪拌することによってホルメ−
トをその対応するアルコ−ルに変換することを含んでい
る。段階(d)は約0℃で不活性ガス好ましくは窒素下
で中性無水溶媒(好ましくは無水エ−テル)中で触媒量
のNaH(約0.1当量)の存在下でトリクロロアセト
ニトリルを6−ヒドロキシ−4−ヘキセン酸エチルと反
応させることを含んでおり、その場でイミデ−トの中間
体(5)を形成し、これは熱転移によって4−トリクロ
ロアセトアミド−5−ヘキセン酸エチル(6)に転換さ
れ、この転移はオバ−マン(Overman), L.J., Am.Chem.S
oc. 98, 2901, 1976の技術を使用して実施される。最終
段階はイミデ−トの好ましくは酸加水分解による加水分
解を含むが、別の方法として塩基性加水分解条件を使用
することもでき、そのHCl塩として所望の4−アミノ
−ヘキセン酸を生じる。遊離酸又は製薬上受け入れられ
るその塩がこの技術分野でよく知られた標準の手順で得
られる。
る。
いか又は形成することがなく、又どんな危険な反応体又
は溶媒も使用されない。
ができる(馬鈴薯澱粉)。
1回の精製で行なうことができる。
れない。
ルトアセテ−ト)及び溶媒(例えばキシレン)の過剰が
回収でき再循環できる。
題が存在せず、生成物はクロマトグラフィのワ−クアッ
プの必要なしに精製できる。
る。
ン 水性蟻酸(150g、75%)中のエリスリト−ル(5
0g、0.5mole)の溶液を100℃以上に12時
間加熱し、次に水及び蟻酸を留去し、反応混合物をブン
ゼンバ−ナ−で200℃以上に加熱した。生成物を蒸留
(沸点230℃、30g)で集め、そして精留すべきで
ある(沸点90℃、15mn)。1 H NMR(90MHz)(CDCl3,TMS)δp
pm.3.23(s,1H,OH),3.6(m,1
H,CH),4.23(t,2H,CH2),5.33
(m,2H,CH2=),5.83(m,1H,−CH
=),8.16(s,1H,HCO2)。
酸エチル トリエチルオルトアセテ−ト(6g、40mmol)中
の4−ホルミロキシ−3−ヒドロキシ−1−ブテン
(1.06g,10mmol)及びプロピオン酸(1
滴)の溶液を140℃でエタノ−ルの蒸留除去の条件下
で加熱した。2時間後、過剰のエチルオルトアセテ−ト
を真空で蒸留除去した。残留物を水で加水分解し、Ac
OEtで抽出した。生成物をSiO2上でフラッシュク
ロマトグラフィで精製した(溶離剤 AcOEt:ヘキ
サン、2:8)(1g、60%)。しかし、蒸留による
精製が大量の場合には好ましい。1 H NMR(90MHz)(CDCl3,TMS)δp
pm.1.26(t,3H,CH3,J=6Hz),
2.4(s,4H,(CH2)2),4.1(q,2H,
CH2,J=6Hz),4.6(d,2H,CH2−C
=,J=6Hz),5.73(m,2H,CH=C
H),8.06(s,1H,HCO2)。
エチル 数滴のアルコ−ル性HCLガスの飽和溶液を含有してい
る無水EtOH(10mL)中の6−ホルミロキシ−6
−ヘキセン酸エチル(0.9g、5mmol)の溶液を
2時間20℃で放置した。溶媒を真空で除去し、残留物
を更に精製することなしに次の段階で使用した(0.7
g、定量的)。この化合物はSiO2上のフラッシュク
ロマトグラフィによって部分的に分解することがわかっ
た。1 H NMR(90MHz)(CDCl3,TMS)δp
pm.1.26(t,3H,CH3,J=6Hz),
2.4(s,4H,(CH2)2),2.83(s,1
H,OH),4.1(s,2H,CH2−C=),4.
16(q,2H,CH3CH2,J=6Hz),5.7
(s,2H,CH=CH)。
−ヘキセン酸エチル 水素化ナトリウム(油中の50%分散液0.03g、
0.5mmol)をN2下で0℃で無水エ−テル(50
mL)中の6−ヒドロキシ−4−ヘキセン酸エチル
(0.7g、5mmol)とトリクロロアセトニトリル
(0.6g、5mmol)の溶液に加えた。1時間後、
エタノ−ル(0.5mmol)を加え、溶媒を真空で除
去した。イミデ−トの形成をNMR(NH,〜8.5p
pm)でコントロ−ルした。キシレン(30mL)中の
粗イミデ−トの溶液を48時間還流で加熱した。次に溶
媒を真空で除去し、残留物をSiO2上のフラッシュク
ロマトグラフィで精製した(溶離液AcOEt:ヘキサ
ン、2:8)。そして表題生成物を得た(1.1g、〜
70%)。1 H NMR(90MHz)(CDCl3,TMS)δp
pm.1.23(t,3H,CH3,J=6Hz),
2.0(t,2H,CH2−CH2−CO2,J=5H
z),2.36(s,2H,CH2CO2),4.1
(q,2H,CH3CH2,J=6Hz),4.4(t,
1H,CH−CH2,J=5Hz),5.1(m,2
H,CH2),5.76(m,1H,CH=CH2),
7.2(s,1H,NH)。 資料を分析のために蒸留
した(沸点150℃、0.5mmHg)。 元素分析C10H14NO3Cl3に対する計算値: C:39.69 H:4.66 N:4.64 実測値: C:39.87 H:4.62 N:4.49
ミド−5−ヘキセン酸エチル(0.3g、1mmol)
の懸濁液を還流下で6時間加熱した。次に混合物を真空
で濃縮し、水(10mL)で希釈し、二度AcOEtで
洗浄し、真空で乾燥し、表題生成物(0.18g、10
0%)を得た。NMR、TLC(NH4OH:EtO
H,3:7)は4−アミノ−5−ヘキセン酸の本物の試
料のものと同じだった。1 H NMR(90MHz)(D2O)δppm.(TM
S)1.83(m,2H,CH2CO2),2.33
(m,2H,CH2CH2),3.66(m,1H,CH
−C=),5.35(m,3H,CH2=CH)。
Claims (4)
- 【請求項1】(a)エリスリト−ルを4−ホルミル−3
−ヒドロキシ−1−ブテンに熱転移させ、 (b)4−ホルミル−3−ヒドロキシ−1−ブテンを6
−ホルミロキシ−4−ヘキセン酸エチルに熱転移させ、
続いてこのホルメ−トを対応するアルコ−ルに変換し、 (c)そのようにして製造した6−ヒドロキシ−4−ヘ
キセン酸エチルをトリクロロアセトニトリルとの反応に
よって6−トリクロロアセトイミドキシ−4−ヘキセン
酸エチルに変換し、続いてその熱転移によってそのイミ
デ−トの4−トリクロロアセトアミド−5−エキセン酸
エチルにし、これを加水分解によって所望の4−アミノ
−5−ヘキセン酸に変換し、そして任意付加的にその酸
を製薬上受け入れられるその塩に変換することもあり得
ることからなる、4−アミノ−5−ヘキセン酸及び製薬
上受け入れられるその塩を製造する方法。 - 【請求項2】6−ホルミロキシ−4−ヘキセン酸エチ
ル。 - 【請求項3】6−トリクロロアセトイミドキシ−4−ヘ
キセン酸エチル。 - 【請求項4】4−トリクロロアセトアミド−5−ヘキセ
ン酸エチル。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91403351A EP0546230A1 (en) | 1991-12-10 | 1991-12-10 | Novel process for preparing 4-amino-5-hexenoic acid |
FR91403351.9 | 1991-12-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05310659A true JPH05310659A (ja) | 1993-11-22 |
JP3229408B2 JP3229408B2 (ja) | 2001-11-19 |
Family
ID=8208648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP35107892A Expired - Lifetime JP3229408B2 (ja) | 1991-12-10 | 1992-12-07 | 新規な4−アミノ−5−ヘキセン酸の製法 |
Country Status (19)
Country | Link |
---|---|
US (4) | US5380936A (ja) |
EP (3) | EP0546230A1 (ja) |
JP (1) | JP3229408B2 (ja) |
KR (2) | KR100248550B1 (ja) |
AR (1) | AR247723A1 (ja) |
AT (2) | ATE163916T1 (ja) |
AU (1) | AU658699B2 (ja) |
CA (1) | CA2084109C (ja) |
DE (2) | DE69224760T2 (ja) |
DK (2) | DK0718273T3 (ja) |
ES (2) | ES2102482T3 (ja) |
FI (1) | FI114632B (ja) |
GR (2) | GR3023608T3 (ja) |
HU (2) | HU9203897D0 (ja) |
IL (5) | IL104013A (ja) |
NO (1) | NO300731B1 (ja) |
NZ (1) | NZ245398A (ja) |
TW (1) | TW224086B (ja) |
ZA (1) | ZA929443B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7863443B2 (en) | 2007-08-22 | 2011-01-04 | Sumitomo Chemical Company, Limited | Phosphoramidite ligand and production method of allylic amine using the same |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010101952A1 (en) * | 2009-03-02 | 2010-09-10 | Wordlock, Inc. | Combination lock assemblies and methods for making combination lock assemblies including random selection of characters |
WO2010101957A1 (en) * | 2009-03-02 | 2010-09-10 | Wordlock, Inc. | Combination lock assemblies and methods for marking combination lock assemblies including distributions of consonants and vowels |
EP2537827B1 (en) | 2011-06-24 | 2014-06-11 | Targeon SAS | Process for preparing 4-amino-5-hexenoic acid from succinimide |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US31980A (en) * | 1861-04-09 | Duane hull | ||
US3879448A (en) * | 1970-02-07 | 1975-04-22 | Takeda Chemical Industries Ltd | 4-hexenoic compounds |
FR2085653B1 (ja) * | 1970-04-30 | 1973-06-08 | Roussel Uclaf | |
US4039549A (en) * | 1975-03-18 | 1977-08-02 | Merrell Toraude Et Compagnie | Olefinic derivatives of amino acids |
US3960927A (en) * | 1975-03-18 | 1976-06-01 | Richardson-Merrell Inc. | Olefinic derivatives of amino acids |
USRE31980E (en) * | 1975-03-18 | 1985-09-03 | Merrell Toraude Et Compagnie | Olefinic derivatives of amino acids |
US4178463A (en) * | 1978-01-30 | 1979-12-11 | Merrell Toraude Et Compagnie | Process for making 4-aminohex-5-enoic acid |
US4672140A (en) * | 1981-01-02 | 1987-06-09 | Monsanto Company | Acyloxyalkenoic acids and process therefor |
US4692538A (en) * | 1982-04-14 | 1987-09-08 | Bristol-Myers Company | Trichloroethanimidic acid esters |
GB2133002B (en) * | 1982-12-30 | 1986-01-29 | Merrell Toraude & Co | Process for preparing 4-amino-5-hexenoic acid |
US4912232A (en) * | 1983-10-14 | 1990-03-27 | Dow Chemical Company | Preparation of N-hydrocarbylcarbonyl-5-(1-hydrocarbylcarbonyloxy)hydrocarbyl-pyrrolidin-2-one |
DE3568771D1 (en) * | 1984-10-10 | 1989-04-20 | Givaudan & Cie Sa | Hexanoates, process for their preparation and perfumes and/or flavouring agents having a content of such compounds |
ES2053582T3 (es) * | 1986-08-13 | 1994-08-01 | Ciba Geigy Ag | Procedimiento para la obtencion de derivados del acido 5-amino-4-hidroxivalerianico. |
YU48319B (sh) * | 1988-08-01 | 1998-05-15 | Monsanto Company | Bezbednosni herbicidni derivati benzoeve kiseline |
AU629419B2 (en) * | 1989-11-07 | 1992-10-01 | Aventis Inc. | Process for the production of vinyl-gaba |
DE4010709A1 (de) * | 1990-04-03 | 1991-10-10 | Huels Chemische Werke Ag | Verfahren zur herstellung von 3-carboxamido-5-vinyl-2-pyrrolidon |
JPH0692903A (ja) * | 1992-09-09 | 1994-04-05 | Yuki Gosei Kogyo Co Ltd | 5−ホルミルオキシ−3−ペンテン酸またはそのエステルおよびその製造法 |
-
1991
- 1991-12-10 EP EP91403351A patent/EP0546230A1/en not_active Withdrawn
-
1992
- 1992-11-30 CA CA002084109A patent/CA2084109C/en not_active Expired - Lifetime
- 1992-12-04 ZA ZA929443A patent/ZA929443B/xx unknown
- 1992-12-04 AU AU29886/92A patent/AU658699B2/en not_active Expired
- 1992-12-07 AT AT96200414T patent/ATE163916T1/de active
- 1992-12-07 EP EP96200414A patent/EP0718273B1/en not_active Expired - Lifetime
- 1992-12-07 IL IL104013A patent/IL104013A/xx not_active IP Right Cessation
- 1992-12-07 AT AT92403296T patent/ATE151070T1/de active
- 1992-12-07 DK DK96200414.9T patent/DK0718273T3/da active
- 1992-12-07 DK DK92403296.4T patent/DK0546906T3/da active
- 1992-12-07 DE DE69224760T patent/DE69224760T2/de not_active Expired - Lifetime
- 1992-12-07 IL IL11696792A patent/IL116967A/xx not_active IP Right Cessation
- 1992-12-07 TW TW081109783A patent/TW224086B/zh not_active IP Right Cessation
- 1992-12-07 JP JP35107892A patent/JP3229408B2/ja not_active Expired - Lifetime
- 1992-12-07 IL IL11696892A patent/IL116968A/en not_active IP Right Cessation
- 1992-12-07 DE DE69218736T patent/DE69218736T2/de not_active Expired - Lifetime
- 1992-12-07 ES ES92403296T patent/ES2102482T3/es not_active Expired - Lifetime
- 1992-12-07 ES ES96200414T patent/ES2116130T3/es not_active Expired - Lifetime
- 1992-12-07 IL IL11696896A patent/IL116968A0/xx unknown
- 1992-12-07 EP EP92403296A patent/EP0546906B1/en not_active Expired - Lifetime
- 1992-12-08 NZ NZ24539892A patent/NZ245398A/en unknown
- 1992-12-08 KR KR1019920023550A patent/KR100248550B1/ko not_active IP Right Cessation
- 1992-12-09 FI FI925592A patent/FI114632B/fi not_active IP Right Cessation
- 1992-12-09 NO NO924763A patent/NO300731B1/no not_active IP Right Cessation
- 1992-12-09 HU HU9203897A patent/HU9203897D0/hu unknown
- 1992-12-09 HU HU9203897A patent/HU213374B/hu unknown
- 1992-12-09 AR AR92323844A patent/AR247723A1/es active
-
1994
- 1994-01-19 US US08/184,762 patent/US5380936A/en not_active Expired - Lifetime
- 1994-07-22 US US08/279,620 patent/US5440065A/en not_active Expired - Lifetime
-
1995
- 1995-04-11 US US08/420,178 patent/US5473099A/en not_active Expired - Fee Related
- 1995-04-11 US US08/420,179 patent/US5512698A/en not_active Expired - Fee Related
-
1996
- 1996-01-30 IL IL11696796A patent/IL116967A0/xx unknown
-
1997
- 1997-05-30 GR GR970401252T patent/GR3023608T3/el unknown
-
1998
- 1998-04-03 GR GR980400706T patent/GR3026522T3/el unknown
-
1999
- 1999-08-30 KR KR1019990036254A patent/KR100249593B1/ko not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7863443B2 (en) | 2007-08-22 | 2011-01-04 | Sumitomo Chemical Company, Limited | Phosphoramidite ligand and production method of allylic amine using the same |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3229408B2 (ja) | 新規な4−アミノ−5−ヘキセン酸の製法 | |
JP4703012B2 (ja) | 3−ヒドロキシプロピオニトリルの製造方法 | |
JP2620437B2 (ja) | ω−ヒドロキシ−(ω−3)−ケトニトリルおよびω−ヒドロキシ脂肪酸の製法 | |
US6072074A (en) | Process for producing 3-propynyl-2-2-dimethylcycloprophane-carboxylic acid and its lower akyl esters | |
JPH0466216B2 (ja) | ||
JP4754085B2 (ja) | ラバンジュラールの製造方法 | |
JP3513726B2 (ja) | 2置換−1,3−インダンジオン誘導体の製造法 | |
JPS6232188B2 (ja) | ||
EP0663394B1 (en) | Process for preparing 5-aminodihydropyrrole, intermediate thereof and process for preparing said intermediate | |
HU213386B (en) | Process for the preparation of ethyl-6-(formyl-oxy)- and ethyl-6-(trichloroacetimidoyl-oxy)-4-hexenoate | |
JPH082882B2 (ja) | ピリジン−2,3−ジカルボン酸誘導体の製法 | |
JPH0696564B2 (ja) | α−(ω−ヒドロキシアルキル)フルフリルアルコ−ル及びその製造法 | |
JPH06772B2 (ja) | 3―(4―フルオロフエノキシ)プロピオニトリルを用いる6―フルオロ―4―クロマノンの製造法 | |
JP2000063321A (ja) | 光学純度の高い長鎖β−ヒドロキシカルボン酸の製造方法 | |
JPH10298173A (ja) | 4−ヒドロキシ−2−ブテノリド類の製造方法 | |
JP2542274B2 (ja) | 3―[4―(1―イミダゾリルメチル)フェニル]―2―プロペン―1―アル及びその製造方法 | |
JPH1095760A (ja) | シアノ酢酸エステルの製造法 | |
JP3293676B2 (ja) | ハロマレイン酸およびハロフマル酸エステル類の製造方法 | |
US4367346A (en) | Method for synthesis of long-chain alcohols | |
JPS6346057B2 (ja) | ||
JPH0841005A (ja) | 4−フルオルアルコキシシンナモニトリル類の製法 | |
JP2780316B2 (ja) | フェノールケトン化合物の製造方法 | |
JPH053859B2 (ja) | ||
JPH082880B2 (ja) | ピリジン−2,3−ジカルボン酸誘導体の製法 | |
JPH06157496A (ja) | ベンジルエステル誘導体及びその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080907 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080907 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090907 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100907 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100907 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110907 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120907 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130907 Year of fee payment: 12 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130907 Year of fee payment: 12 |